OSL •
Healthcare •
Biotechnology •
Quote as of 09/08/2026 16:25
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOSL
Market Capitalization1,998.01 mln
Float153 mln
Earnings Date02/26/2027
Piotroski F-Score
2
/ 9
Weak
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
0.38
Low leverage
Pre-Tax Margin
-12,460%
Severely loss-making
ROE
-13.74
Negative
Dividend Yield
0.00%
No dividend
Business Description
Thor Medical ASA is a Norwegian company focused on developing radioactive materials used in targeted cancer treatments. Founded in 2009 and based in Oslo, the company works with a range of specialized isotopes derived from the thorium decay chain. Its work supports a growing field of medicine that uses alpha-emitting particles to attack cancer cells with precision.
